Format
Sort by

Send to

Choose Destination

Search results

Items: 4

1.

Interplay between cigarette smoking and pulmonary reverse lipid transport.

Jubinville É, Talbot M, Bérubé JC, Hamel-Auger M, Maranda-Robitaille M, Beaulieu MJ, Aubin S, Paré MÈ, Kallend DG, Arsenault B, Bossé Y, Morissette MC.

Eur Respir J. 2017 Sep 9;50(3). pii: 1700681. doi: 10.1183/13993003.00681-2017. Print 2017 Sep.

2.

MDCO-216 Does Not Induce Adverse Immunostimulation, in Contrast to Its Predecessor ETC-216.

Reijers JAA, Kallend DG, Malone KE, Jukema JW, Wijngaard PLJ, Burggraaf J, Moerland M.

Cardiovasc Drugs Ther. 2017 Aug;31(4):381-389. doi: 10.1007/s10557-017-6746-x.

3.

A single infusion of MDCO-216 (ApoA-1 Milano/POPC) increases ABCA1-mediated cholesterol efflux and pre-beta 1 HDL in healthy volunteers and patients with stable coronary artery disease.

Kallend DG, Reijers JA, Bellibas SE, Bobillier A, Kempen H, Burggraaf J, Moerland M, Wijngaard PL.

Eur Heart J Cardiovasc Pharmacother. 2016 Jan;2(1):23-9. doi: 10.1093/ehjcvp/pvv041. Epub 2015 Dec 11.

4.

High-Density Lipoprotein Subfractions and Cholesterol Efflux Capacities After Infusion of MDCO-216 (Apolipoprotein A-IMilano/Palmitoyl-Oleoyl-Phosphatidylcholine) in Healthy Volunteers and Stable Coronary Artery Disease Patients.

Kempen HJ, Asztalos BF, Moerland M, Jeyarajah E, Otvos J, Kallend DG, Bellibas SE, Wijngaard PL.

Arterioscler Thromb Vasc Biol. 2016 Apr;36(4):736-42. doi: 10.1161/ATVBAHA.115.307052. Epub 2016 Feb 25.

PMID:
26916733

Supplemental Content

Loading ...
Support Center